CYBERGUN SA (ALCYB.PA) Fundamental Analysis & Valuation
EPA:ALCYB • FR0014004QR6
Current stock price
0.0004 EUR
0 (-20%)
Last:
This ALCYB.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ALCYB.PA Profitability Analysis
1.1 Basic Checks
- In the past year ALCYB has reported negative net income.
- In the past year ALCYB has reported a negative cash flow from operations.
- In the past 5 years ALCYB reported 4 times negative net income.
- In the past 5 years ALCYB always reported negative operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of -27.57%, ALCYB is doing worse than 85.71% of the companies in the same industry.
- With a Return On Equity value of -107.44%, ALCYB is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -27.57% | ||
| ROE | -107.44% | ||
| ROIC | N/A |
ROA(3y)-12.03%
ROA(5y)-24.01%
ROE(3y)-37.16%
ROE(5y)-580.68%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- ALCYB has a Gross Margin (40.24%) which is in line with its industry peers.
- ALCYB's Gross Margin has improved in the last couple of years.
- ALCYB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 40.24% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.43%
GM growth 5Y25.11%
2. ALCYB.PA Health Analysis
2.1 Basic Checks
- ALCYB does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, ALCYB has more shares outstanding
- Compared to 1 year ago, ALCYB has a worse debt to assets ratio.
2.2 Solvency
- ALCYB has an Altman-Z score of -0.10. This is a bad value and indicates that ALCYB is not financially healthy and even has some risk of bankruptcy.
- ALCYB's Altman-Z score of -0.10 is on the low side compared to the rest of the industry. ALCYB is outperformed by 85.71% of its industry peers.
- ALCYB has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
- With an excellent Debt to Equity ratio value of 0.13, ALCYB belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.1 |
ROIC/WACCN/A
WACC5.25%
2.3 Liquidity
- A Current Ratio of 1.01 indicates that ALCYB should not have too much problems paying its short term obligations.
- Looking at the Current ratio, with a value of 1.01, ALCYB is doing worse than 78.57% of the companies in the same industry.
- ALCYB has a Quick Ratio of 1.01. This is a bad value and indicates that ALCYB is not financially healthy enough and could expect problems in meeting its short term obligations.
- ALCYB has a Quick ratio of 0.44. This is amonst the worse of the industry: ALCYB underperforms 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.01 | ||
| Quick Ratio | 0.44 |
3. ALCYB.PA Growth Analysis
3.1 Past
- ALCYB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -3372.58%.
- ALCYB shows a decrease in Revenue. In the last year, the revenue decreased by -1.46%.
- The Revenue has been growing slightly by 5.94% on average over the past years.
EPS 1Y (TTM)-3372.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.89%
Revenue 1Y (TTM)-1.46%
Revenue growth 3Y1.97%
Revenue growth 5Y5.94%
Sales Q2Q%-15.26%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. ALCYB.PA Valuation Analysis
4.1 Price/Earnings Ratio
- ALCYB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. ALCYB.PA Dividend Analysis
5.1 Amount
- ALCYB does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ALCYB.PA Fundamentals: All Metrics, Ratios and Statistics
EPA:ALCYB (8/1/2025, 7:00:00 PM)
0.0004
0 (-20%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)10-31 2024-10-31
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.89M
Revenue(TTM)42.69M
Net Income(TTM)-14.61M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.07 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.21 | ||
| P/tB | 0.55 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.2
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.01
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -27.57% | ||
| ROE | -107.44% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 40.24% | ||
| FCFM | N/A |
ROA(3y)-12.03%
ROA(5y)-24.01%
ROE(3y)-37.16%
ROE(5y)-580.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.43%
GM growth 5Y25.11%
F-Score4
Asset Turnover0.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 33.45% | ||
| Cap/Sales | 1.11% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.01 | ||
| Quick Ratio | 0.44 | ||
| Altman-Z | -0.1 |
F-Score4
WACC5.25%
ROIC/WACCN/A
Cap/Depr(3y)164.05%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.65%
Cap/Sales(5y)5.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3372.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.46%
Revenue growth 3Y1.97%
Revenue growth 5Y5.94%
Sales Q2Q%-15.26%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-495.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y66.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.3%
OCF growth 3YN/A
OCF growth 5YN/A
CYBERGUN SA / ALCYB.PA Fundamental Analysis FAQ
What is the fundamental rating for ALCYB stock?
ChartMill assigns a fundamental rating of 1 / 10 to ALCYB.PA.
Can you provide the valuation status for CYBERGUN SA?
ChartMill assigns a valuation rating of 0 / 10 to CYBERGUN SA (ALCYB.PA). This can be considered as Overvalued.
What is the profitability of ALCYB stock?
CYBERGUN SA (ALCYB.PA) has a profitability rating of 1 / 10.
How financially healthy is CYBERGUN SA?
The financial health rating of CYBERGUN SA (ALCYB.PA) is 2 / 10.